Clinical, Biophysical and Market Evaluation of the Temple Wearable and its Real Time Autonomic Entropy Biomarker

Deep-tech health monitoring has emerged as a major point of convergence for consumer electronics and longevity science. A notable project in this landscape is Temple, a neuro-technology and biological monitoring startup founded in 2024 by Deepinder Goyal, the founder and executive chairman of the Indian consumer internet giant Zomato. 

The initiative originated within Continue Research, a highly specialised, research-heavy division of Eternal, which serves as the parent conglomerate of Zomato and Blinkit. After operating in stealth mode for approximately two years, Temple emerged publicly in early 2026 following a fifty-four million dollar seed funding round that valued the startup at one hundred and ninety million dollars. Goyal positioned himself as the primary developer and "Patient Zero" for the technology, committing approximately twenty-five million dollars of his own capital to fund the early research and development cycles of the prototype.
 
The development of Temple is closely tied to Goyal's personal interest in longevity and physiological optimisation. His personal routine, comprising blood tracking, fasting, meditation, hyperbaric chamber protocols and intensive supplementation, gradually focused on brain-specific circulation and cognitive health. This transition from consumer internet operations to human performance hardware reflects a broader industry trend of technology executives funding deep-tech research in areas like neuroscience and preventive healthcare.
  
Conceptual and Biophysical Foundations of Entropy
  
The selection of the term "Entropy" as Temple's flagship biomarker reflects a conceptual theme that spans Goyal's organizational and physiological philosophies. In corporate operations, Goyal has historically framed systemic challenges through the lens of thermodynamics, noting that the attrition and re-entry of employees creates a productive organizational "entropy" that propels institutional context forward. In the physical and biological domains, entropy represents the inevitable progression of a closed system toward thermodynamic equilibrium, chaos and structural decay. Living organisms, operating as open thermodynamic networks, must constantly perform work to capture "negative entropy" from their environments to maintain baseline internal order.
  
Temple operationalises this biophysical principle by defining its trademarked biomarker, Entropy™, as the real-time metabolic and sympathetic demand under which the body operates. The metric is designed to quantify "the cost the body pays to be alive". A highly resilient, healthy organism is characterised by maintaining a low baseline level of autonomic entropy at rest, while retaining the capacity to surge and recover rapidly when subjected to physical or cognitive stressors. Conversely, an inability to return to baseline or a chronically elevated resting entropy state is clinically associated with physiological rigidity, chronic sympathetic dominance and accelerated biological aging.
  
From a signal processing standpoint, physiological entropy is computed using non-linear algorithms such as Sample Entropy (SampEn) or Multiscale Entropy (MSE) applied to continuous pulse-to-pulse intervals (R\text{-}Rintervals) or arterial pressure wave fluctuations. 
  
Sample Entropy is mathematically defined as:cSampEn(m, r, N) = -\ln \left( \frac{A}{B} \right)
  
where m represents the template length, r represents the vector comparison tolerance, $N$ is the total data length, B is the number of matching template vectors of length m, and A is the number of matching template vectors of length m+1. A higher entropy value indicates a complex, irregular and highly adaptive physiological signal, whereas a lower entropy value reflects physiological rigidity, chronic sympathetic over activation, or system failure.

Click here to read the report https://www.healthcare.digital/single-post/clinical-biophysical-and-market-evaluation-of-the-temple-wearable-and-its-real-time-autonomic-entro

To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email [email protected]